EU-funded researchers have developed a DNA test to help determine the correct dose of anticoagulant medication for people at risk of thrombosis, a blood-clotting condition that affects millions worldwide. Their work is advancing the emerging field of pharmacogenetics that aims to provide patients with personalised and more effective treatment based on their genetic profile.from EUROPA - Syndicated Research News Feed http://ift.tt/1P5b7ye
via IFTTT
No comments:
Post a Comment